ADVENTRX Pharmaceuticals (ANX) Reports In-Line Q3 EPS Loss of $0.13
Tweet
Share
E-mailGet Alerts ANX Hot Sheet
Price: $0.73 --0%
Financial Fact:
Selling, general and administrative: 2.13M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, general and administrative: 2.13M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
